A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
The Federal Communications Commission was roundly criticized today for proposing to scale back or eliminate E-Rate, a $2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results